Curated coverage for rapamycin with top developments, timeline context, and connected threads.
Dozens of compounds extend lifespan in mice. Almost none have worked in human trials. Here is the biology behind the translation gap and the researchers who think they know how to cross it.
EuroBulletin24 Editorial Desk | Linked source
The Dog Aging Project's rapamycin trial results are in. Here is what they show and why they change the landscape of human longevity research.
The Dog Aging Project's rapamycin trial is expected to report results in 2026. Here is why this experiment matters for human longevity science and what it could change.